Literature DB >> 30621826

Evaluation of Home Polysomnography Findings, Quality of Sleep, and Fatigue in Inflammatory Bowel Disease: A Case Series.

Deise Lun Paixão1, Dalva Poyares2,3, Marta Sevilh de Paula3, Joselmo Willamy Duarte1, Paula Midor Castelo4, Orlando Ambrogini-Júnior5, Sender Jankie Miszputen5, Celina Tizuko Fujiyam Oshima1,5, Jair Ribeir Chagas2, Ana Paula Ribeir Paiotti1,5.   

Abstract

STUDY
OBJECTIVES: The pathogenesis of inflammatory bowel disease (IBD) is not well understood, and sleep disorders may be potential triggers for IBD. Thus, an evaluation of the sleep characteristics, fatigue symptoms, and cytokine levels was performed in patients with IBD during periods of active disease and remission.
METHODS: A total of 20 participants presenting with Crohn's disease or ulcerative colitis, with active disease (n = 7) or in remission (n = 13), underwent home polysomnography (H-PSG). Pittsburgh Sleep Quality Index (PSQI) and Modified Fatigue Impact Scale (MFIS) were applied, in addition to the evaluation of interleukin (IL)-6, IL-10, and tumor necrosis factor alpha (TNF-α) serum levels. Exploratory analysis, t test and Mann-Whitney U test were used.
RESULTS: The mean sleep latency in patients with active disease was 133.07 minutes and 106.79 minutes in those in remission. The sleep efficiency and sleep fragmentation in patients with active disease and those in remission were 80.90% and 84.20% (median), and 76.36/min and 69.82/min (mean), respectively, although the H-PSG parameters did not differ between the groups. The PSQI scores indicated poor sleep quality (global score above 5) in all participants with IBD, and the participants with active disease presented more symptoms of fatigue (P = .032). IL-6 and TNF-α average levels were higher in the participants with disease remission, although with a larger dispersion of the data.
CONCLUSIONS: No significant difference in the H-PSG characteristics was observed between the patients with IBD with active disease and those in remission; however, the perception of the participants with IBD showed significant effect on the sleep quality and fatigue symptoms.
© 2019 American Academy of Sleep Medicine.

Entities:  

Keywords:  fatigue; inflammatory bowel disease; interleukins; polysomnography; sleep disorders

Year:  2019        PMID: 30621826      PMCID: PMC6329559          DOI: 10.5664/jcsm.7566

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  38 in total

Review 1.  The influence of stress on the development and severity of immune-mediated diseases.

Authors:  David S Rampton
Journal:  J Rheumatol Suppl       Date:  2011-11

Review 2.  Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery.

Authors:  Brice Faraut; Karim Zouaoui Boudjeltia; Luc Vanhamme; Myriam Kerkhofs
Journal:  Sleep Med Rev       Date:  2011-08-10       Impact factor: 11.609

Review 3.  The epidemiology of inflammatory bowel disease.

Authors:  Johan Burisch; Pia Munkholm
Journal:  Scand J Gastroenterol       Date:  2015-02-17       Impact factor: 2.423

4.  Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

Authors:  N Téllez; J Río; M Tintoré; C Nos; I Galán; X Montalban
Journal:  Mult Scler       Date:  2005-04       Impact factor: 6.312

5.  Chronic disruptions of circadian sleep regulation induce specific proinflammatory responses in the rat colon.

Authors:  Lenka Polidarová; Pavel Houdek; Alena Sumová
Journal:  Chronobiol Int       Date:  2017-10-17       Impact factor: 2.877

6.  Sleep stage distribution in persons with mild traumatic brain injury: a polysomnographic study according to American Academy of Sleep Medicine standards.

Authors:  Tatyana Mollayeva; Angela Colantonio; J David Cassidy; Lee Vernich; Rahim Moineddin; Colin M Shapiro
Journal:  Sleep Med       Date:  2017-03-18       Impact factor: 3.492

Review 7.  Fatigue and quality of sleep in patients with immune-mediated inflammatory disease.

Authors:  Lesley A Graff; John R Walker; Anthony S Russell; Robert Bissonnette; Charles N Bernstein
Journal:  J Rheumatol Suppl       Date:  2011-11

8.  Epidemiology and natural history of inflammatory bowel diseases.

Authors:  Jacques Cosnes; Corinne Gower-Rousseau; Philippe Seksik; Antoine Cortot
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

9.  Effects of sleep and sleep deprivation on interleukin-6, growth hormone, cortisol, and melatonin levels in humans.

Authors:  L Redwine; R L Hauger; J C Gillin; M Irwin
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

Review 10.  Sleep and circadian rhythms in humans.

Authors:  C A Czeisler; J J Gooley
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2007
View more
  5 in total

Review 1.  Sleep Disturbances in the Elderly Patient with Inflammatory Bowel Disease.

Authors:  Taha Qazi; Francis A Farraye
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 2.  Sleep and Fatigue in IBD: an Unrecognized but Important Extra-intestinal Manifestation.

Authors:  Andrew Canakis; Taha Qazi
Journal:  Curr Gastroenterol Rep       Date:  2020-01-30

3.  Quantitative study of the effects of early standardized ambulation on sleep quality in patients after hepatectomy.

Authors:  Chun-Yan Ni; Guo-Jun Hou; Ya-Yuan Tang; Jing-Jing Wang; Wen-Jun Chen; Yuan Yang; Zhi-Hong Wang; Wei-Ping Zhou
Journal:  Front Surg       Date:  2022-09-23

4.  Sleep Characteristics and Rest-Activity Rhythms Are Associated with Gastrointestinal Symptoms Among Adults with Inflammatory Bowel Disease.

Authors:  Samantha Conley; Sangchoon Jeon; Vanessa Lehner; Deborah D Proctor; Nancy S Redeker
Journal:  Dig Dis Sci       Date:  2020-03-19       Impact factor: 3.199

5.  Determinants of Sleep Quality in Inflammatory Bowel Diseases.

Authors:  Marcin Sochal; Ewa Małecka-Panas; Agata Gabryelska; Renata Talar-Wojnarowska; Bartosz Szmyd; Monika Krzywdzińska; Piotr Białasiewicz
Journal:  J Clin Med       Date:  2020-09-10       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.